Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Increasing patient age did not affect efficacy of sentinel lymph node biopsy
September 15th, 2005
Increasing patient age did not affect the efficacy of sentinel lymph node biopsy (SLNB) using smaller-sized technetium-99M tin colloids. "Increasing age of breast cancer patients was reported to cause not only failure of SLN identification but also false negative results. A retrospective review was conducted of breast cancer patients who underwent SLNB using small-sized technetium-99m-labeled tin colloid (particle size: 200-400 nm in diameter)," scientists in Japan reported. "A comparison between 82 patients who were <60 years and 40 patients who were {{>=}}60 years of age was performed to evaluate the efficacy of SLNB using the small-sized tin...
Source: Women's Health Weekly (2005-09-15)
|
